Tomomi Sato
Pharmacological analysis and structure determination of 7-methylcyanopindolol–bound b1-adrenergic receptor
Sato, Tomomi; Baker, Jillian G.; Warne, Tony; Brown, Giles A.; Leslie, Andrew; Congreve, Miles; Tate, Christopher G.
Authors
JILLIAN BAKER jillian.baker@nottingham.ac.uk
Professor of Drug Discovery and Respiratory Medicine
Tony Warne
Giles A. Brown
Andrew Leslie
Miles Congreve
Christopher G. Tate
Abstract
Comparisons between structures of the b1-adrenergic receptor (AR) bound to either agonists, partial agonists, or weak partial agonists led to the proposal that rotamer changes of Ser5.46, coupled to a contraction of the binding pocket, are sufficient to increase the probability of receptor activation. (RS)-4-[3 (tertbutylamino)-2-hydroxypropoxy]-1H-indole-2 carbonitrile (cyanopindolol) is a weak partial agonist of b1AR and, based on the hypothesis above, we predicted that the addition of a methyl group to form 4-[(2S)-3 (tert-butylamino)-2-hydroxypropoxy]-7-methyl-1H-indole-2 carbonitrile (7-methylcyanopindolol) would dramatically reduce its efficacy. An eight-step synthesis of 7- methylcyanopindolol was developed and its pharmacology was analyzed. 7-Methylcyanopindolol bound with similar affinity to cyanopindolol to both b1AR and b2AR. As predicted, the efficacy of 7-methylcyanopindolol was reduced significantly compared with cyanopindolol, acting as a very weak partial agonist of turkey b1AR and an inverse agonist of human b2AR. The structure of 7-methylcyanopindolol–bound b1AR was determined to 2.4-Å resolution and found to be virtually identical to the structure of cyanopindolol-bound b1AR. The major differences in the orthosteric binding pocket are that it has expanded by 0.3 Å in 7-methylcyanopindolol–bound b1AR and the hydroxyl group of Ser5.46 is positioned 0.8 Å further from the ligand, with respect to the position of the Ser5.46 side chain in cyanopindololbound b1AR. Thus, the molecular basis for the reduction in efficacy of 7 methylcyanopindolol compared with cyanopindolol may be regarded as the opposite of the mechanism proposed for the increase in efficacy of agonists compared with antagonists.
Citation
Sato, T., Baker, J. G., Warne, T., Brown, G. A., Leslie, A., Congreve, M., & Tate, C. G. (2015). Pharmacological analysis and structure determination of 7-methylcyanopindolol–bound b1-adrenergic receptor. Molecular Pharmacology, 88(6), https://doi.org/10.1124/mol.115.101030
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 17, 2015 |
Publication Date | Dec 31, 2015 |
Deposit Date | Feb 22, 2017 |
Publicly Available Date | Feb 22, 2017 |
Journal | Molecular Pharmacology |
Print ISSN | 0026-895X |
Electronic ISSN | 1521-0111 |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Peer Reviewed | Peer Reviewed |
Volume | 88 |
Issue | 6 |
DOI | https://doi.org/10.1124/mol.115.101030 |
Public URL | https://nottingham-repository.worktribe.com/output/768381 |
Publisher URL | http://molpharm.aspetjournals.org/content/88/6/1024 |
Contract Date | Feb 22, 2017 |
Files
mol.115.101030.full.pdf
(1.8 Mb)
PDF
You might also like
In vitro and in vivo analysis of a novel highly selective β1-adrenoceptor partial agonist.
(2012)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search